Efficacy of Spironolactone in the Treatment of Patients with Congestive Heart Failure
Shu Sun
Abstract
Shu Sun
Abstract
Object: To evaluate the colincal therapeutic efficacy of spironlactone in patients with chronic congestive heart failure(CHF).Methods: Patients with CHF consisted of 76 cases were randomized into group A and B.In addition,group A was given spironolactone(20-40 mg/d),group B was not given spironolactone.the heart function(by NYHA),echocardiography and the distance after 6 minutes walk test were performed before and after the treatment of six weeks.Results: Six weeks after treatment,NYHA class and the distance after 6 minutes walk test improved significantly in both groups(P0.05),but more significantly in group A than those in group B(P0.05).Conclusion: Use of spironolactone is absolutely reliable for patients with CHF
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Object: To evaluate the colincal therapeutic efficacy of spironlactone in patients with chronic congestive heart failure(CHF).Methods: Patients with CHF consisted of 76 cases were randomized into group A and B.In addition,group A was given spironolactone(20-40 mg/d),group B was not given spironolactone.the heart function(by NYHA),echocardiography and the distance after 6 minutes walk test were performed before and after the treatment of six weeks.Results: Six weeks after treatment,NYHA class and the distance after 6 minutes walk test improved significantly in both groups(P0.05),but more significantly in group A than those in group B(P0.05).Conclusion: Use of spironolactone is absolutely reliable for patients with CHF
Key concepts: Spironolactone, Heart failure, Medicine, Internal medicine, Cardiology, Group B